PALOBIOFARMA, S.L
EIC Accelerator Winner From 2021
Development of the first oral disease-modifying treatment for chronic obstructive pulmonary disease (COPD)
Spain
Articles
EIC Accelerator Funding Fuels PALOBIOFARMA's Innovative Drug Development
SpainEIC Accelerator2021
Read Article